{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,23]],"date-time":"2026-01-23T17:23:04Z","timestamp":1769188984590,"version":"3.49.0"},"reference-count":19,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2018,4,9]],"date-time":"2018-04-09T00:00:00Z","timestamp":1523232000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neurol"],"published-print":{"date-parts":[[2018,6]]},"DOI":"10.1007\/s00415-018-8853-4","type":"journal-article","created":{"date-parts":[[2018,4,9]],"date-time":"2018-04-09T05:19:44Z","timestamp":1523251184000},"page":"1402-1409","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":46,"title":["CANOMAD and other chronic ataxic neuropathies with disialosyl antibodies (CANDA)"],"prefix":"10.1007","volume":"265","author":[{"given":"Rocio","family":"Garcia-Santibanez","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Craig M.","family":"Zaidman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R. Brian","family":"Sommerville","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Glenn","family":"Lopate","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Conrad C.","family":"Weihl","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alan","family":"Pestronk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert C.","family":"Bucelli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,4,9]]},"reference":[{"key":"8853_CR1","doi-asserted-by":"publisher","first-page":"726","DOI":"10.1136\/jnnp.2009.202796","volume":"81","author":"A Pestronk","year":"2010","unstructured":"Pestronk A, Chuquilin M, Choksi R (2010) Motor neuropathies and serum IgM binding to NS6S heparin disaccharide or GM1 ganglioside. J Neurol Neurosurg Psychiatry 81:726\u2013730","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"8853_CR2","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1002\/mus.10301","volume":"27","author":"A Pestronk","year":"2003","unstructured":"Pestronk A, Choksi R, Logigian E, Al-Lozi MT (2003) Sensory neuropathy with monoclonal IgM binding to a trisulfated heparin disaccharide. Muscle Nerve 27:188\u2013195","journal-title":"Muscle Nerve"},{"key":"8853_CR3","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1212\/WNL.41.5.617","volume":"41","author":"Research criteria for diagnosis of chronic inflammatory demyelinating polyneuropathy (CIDP)","year":"1991","unstructured":"Research criteria for diagnosis of chronic inflammatory demyelinating polyneuropathy (CIDP) (1991) Report from an Ad Hoc subcommittee of the American Academy of Neurology AIDS task force. Neurology 41:617\u2013618","journal-title":"Neurology"},{"key":"8853_CR4","doi-asserted-by":"publisher","first-page":"960","DOI":"10.1002\/mus.21431","volume":"40","author":"CM Zaidman","year":"2009","unstructured":"Zaidman CM, Al-Lozi M, Pestronk A (2009) Peripheral nerve size in normals and patients with polyneuropathy: an ultrasound study. Muscle Nerve 40:960\u2013966","journal-title":"Muscle Nerve"},{"key":"8853_CR5","doi-asserted-by":"publisher","first-page":"1178","DOI":"10.1136\/jnnp.56.11.1178","volume":"56","author":"HJ Willison","year":"1993","unstructured":"Willison HJ, Paterson G, Veitch J, Inglis G, Barnett SC (1993) Peripheral neuropathy associated with monoclonal IgM anti-Pr2 cold agglutinins. J Neurol Neurosurg Psychiatry 56:1178\u20131183","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"8853_CR6","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1016\/j.expneurol.2007.09.010","volume":"209","author":"K Takada","year":"2008","unstructured":"Takada K, Shimizu J, Kusunoki S (2008) Apoptosis of primary sensory neurons in GD1b-induced sensory ataxic neuropathy. Exp Neurol 209:279\u2013283","journal-title":"Exp Neurol"},{"key":"8853_CR7","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1002\/mus.23897","volume":"48","author":"PA McKelvie","year":"2013","unstructured":"McKelvie PA, Gates PC, Day T (2013) Canomad: report of a case with a 40-year history and autopsy. Is this a sensory ganglionopathy with neuromuscular junction blockade? Muscle Nerve 48:599\u2013603","journal-title":"Muscle Nerve"},{"key":"8853_CR8","doi-asserted-by":"publisher","first-page":"1426","DOI":"10.1002\/(SICI)1097-4598(199910)22:10<1426::AID-MUS13>3.0.CO;2-H","volume":"22","author":"T Obi","year":"1999","unstructured":"Obi T, Murakami T, Takatsu M et al (1999) Clinicopathological study of an autopsy case with sensory-dominant polyradiculoneuropathy with antiganglioside antibodies. Muscle Nerve 22:1426\u20131431","journal-title":"Muscle Nerve"},{"key":"8853_CR9","doi-asserted-by":"publisher","first-page":"898","DOI":"10.1093\/brain\/awx012","volume":"140","author":"AJ Clark","year":"2017","unstructured":"Clark AJ, Kaller MS, Galino J, Willison HJ, Rinaldi S, Bennett DLH (2017) Co-cultures with stem cell-derived human sensory neurons reveal regulators of peripheral myelination. Brain 140:898\u2013913","journal-title":"Brain"},{"key":"8853_CR10","doi-asserted-by":"publisher","first-page":"1968","DOI":"10.1093\/brain\/124.10.1968","volume":"124","author":"HJ Willison","year":"2001","unstructured":"Willison HJ, O\u2019Leary CP, Veitch J et al (2001) The clinical and laboratory features of chronic sensory ataxic neuropathy with anti-disialosyl IgM antibodies. Brain 124:1968\u20131977","journal-title":"Brain"},{"key":"8853_CR11","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1136\/jnnp.2009.185736","volume":"81","author":"S Attarian","year":"2010","unstructured":"Attarian S, Boucraut J, Hubert AM et al (2010) Chronic ataxic neuropathies associated with anti-GD1b IgM antibodies: response to IVIg therapy. J Neurol Neurosurg Psychiatry 81:61\u201364","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"8853_CR12","doi-asserted-by":"publisher","first-page":"866","DOI":"10.1002\/mus.23256","volume":"45","author":"A Pestronk","year":"2012","unstructured":"Pestronk A, Schmidt RE, Choksi RM, Sommerville RB, Al-Lozi MT (2012) Clinical and laboratory features of neuropathies with serum IgM binding to TS-HDS. Muscle Nerve 45:866\u2013872","journal-title":"Muscle Nerve"},{"key":"8853_CR13","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1007\/s004150070090","volume":"247","author":"S Erb","year":"2000","unstructured":"Erb S, Ferracin F, Fuhr P et al (2000) Polyneuropathy attributes: a comparison between patients with anti-MAG and anti-sulfatide antibodies. J Neurol 247:767\u2013772","journal-title":"J Neurol"},{"key":"8853_CR14","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1212\/WNL.0000000000003483","volume":"88","author":"HS Goedee","year":"2017","unstructured":"Goedee HS, van der Pol WL, van Asseldonk JH et al (2017) Diagnostic value of sonography in treatment-naive chronic inflammatory neuropathies. Neurology 88:143\u2013151","journal-title":"Neurology"},{"key":"8853_CR15","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1016\/j.clinph.2013.07.023","volume":"125","author":"L Padua","year":"2014","unstructured":"Padua L, Granata G, Sabatelli M et al (2014) Heterogeneity of root and nerve ultrasound pattern in CIDP patients. Clin Neurophysiol 125:160\u2013165","journal-title":"Clin Neurophysiol"},{"key":"8853_CR16","doi-asserted-by":"publisher","first-page":"1307","DOI":"10.1212\/WNL.61.9.1307","volume":"61","author":"K Siddiqui","year":"2003","unstructured":"Siddiqui K, Cahalane E, Keogan M, Hardiman O (2003) Chronic ataxic neuropathy with cold agglutinins: atypical phenotype and response to anti-CD20 antibodies. Neurology 61:1307\u20131308","journal-title":"Neurology"},{"key":"8853_CR17","doi-asserted-by":"publisher","first-page":"1168","DOI":"10.1007\/s00415-013-6867-5","volume":"260","author":"WN Loscher","year":"2013","unstructured":"Loscher WN, Woertz A, Wallnofer M, Wanschitz JV, Luef G (2013) Successful treatment of CANOMAD with IVIg and rituximab. J Neurol 260:1168\u20131170","journal-title":"J Neurol"},{"key":"8853_CR18","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1007\/s00415-009-5412-z","volume":"257","author":"E Delmont","year":"2010","unstructured":"Delmont E, Jeandel PY, Hubert AM, Marcq L, Boucraut J, Desnuelle C (2010) Successful treatment with rituximab of one patient with CANOMAD neuropathy. J Neurol 257:655\u2013657","journal-title":"J Neurol"},{"key":"8853_CR19","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1002\/mus.22167","volume":"44","author":"C Kam","year":"2011","unstructured":"Kam C, Balaratnam MS, Purves A et al (2011) Canomad presenting without ophthalmoplegia and responding to intravenous immunoglobulin. Muscle Nerve 44:829\u2013833","journal-title":"Muscle Nerve"}],"container-title":["Journal of Neurology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00415-018-8853-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-018-8853-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-018-8853-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,4,9]],"date-time":"2019-04-09T05:43:01Z","timestamp":1554788581000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00415-018-8853-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,4,9]]},"references-count":19,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2018,6]]}},"alternative-id":["8853"],"URL":"https:\/\/doi.org\/10.1007\/s00415-018-8853-4","relation":{},"ISSN":["0340-5354","1432-1459"],"issn-type":[{"value":"0340-5354","type":"print"},{"value":"1432-1459","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,4,9]]},"assertion":[{"value":"20 February 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 March 2018","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 March 2018","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 April 2018","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"We confirm that we have read the Journal\u2019s position on issues involved in ethical publication and affirm that this report is consistent with those guidelines.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical standards"}},{"value":"All authors have no conflicts of interest.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}}]}}